BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• Drug Development

  Vion Pharmaceuticals to Present Survival Data on Laromustine at American Society of Hematology Annual Meeting

  December 4, 2008

   · 

  3 min read
• Pharm Country

  Enzon Pharmaceuticals, Inc. to Purchase a Portion of Its Outstanding Debt

  December 4, 2008

   · 

  1 min read
• Business

  Healthnostics Reports 40% Revenue Growth Rate in GMD, Inc.

  December 4, 2008

   · 

  1 min read
• Drug Development

  VentiRx Pharmaceuticals, Inc. Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology

  December 4, 2008

   · 

  1 min read
• Deals

  Forest Laboratories, Inc. Responds To Unsolicited Mini-Tender Offer

  December 4, 2008

   · 

  3 min read
• Business

  Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on December 9, 2008

  December 4, 2008

   · 

  1 min read
• CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East

  December 4, 2008

   · 

  4 min read
• Drug Development

  Genta Incorporated Release: Tesetaxel, a Leading Oral Taxane in Clinical Development, Receives FDA Designation as an Orphan Drug for Treatment of Patients with Advanced Melanoma

  December 4, 2008

   · 

  1 min read
• Biotech Bay

  Cepheid to Webcast Upcoming Financial Presentations

  December 4, 2008

   · 

  1 min read
• Drug Development

  Alkermes Initiates Clinical Trial for ALKS 33, a Novel Oral Molecule with Potential Benefits in Addiction and Other CNS Disorders

  December 4, 2008

   · 

  1 min read